I Have PCOS, and Here's How I Feel About Its New Name
Our take
The recent renaming of Polycystic Ovary Syndrome to Polycystic Ovary Metabolic Syndrome (PCOS) has sparked considerable discussion within the health and wellness community, and for good reason. For those, like the author of this piece, who have lived with the condition for years, this shift represents more than just a semantic change; it signals a growing recognition of the multifaceted nature of PCOS. It’s a welcome evolution, moving away from a primarily reproductive focus to acknowledge the systemic metabolic dysfunction at its core. The shift underscores a deeper understanding of how the condition impacts not just ovulation and fertility, but also insulin resistance, cardiovascular health, and mental well-being. This resonates strongly with our audience, many of whom are actively seeking holistic approaches to wellness and are increasingly aware of the interconnectedness of their physical and emotional states, much like the perspective shared in Why the "Love Island USA" Conversation About Colorism Is So Needed. The importance of recognizing and addressing systemic issues, rather than simply treating isolated symptoms, is a theme increasingly relevant to informed self-care.
The original diagnosis of PCOS often felt incomplete, a label applied without fully exploring the underlying metabolic complexities. The term "syndrome" itself suggests a collection of symptoms, but the emphasis historically has been on the ovarian morphology – the polycystic ovaries visible on ultrasound. This narrow view often led to limited treatment options, primarily focused on managing menstrual irregularities and fertility concerns. The new designation, PCOS, more accurately reflects the reality that many individuals with PCOS experience a spectrum of metabolic issues, including insulin resistance, hormonal imbalances beyond those impacting ovulation, and increased risk of type 2 diabetes and cardiovascular disease. This broader perspective is vital for personalized care, moving beyond a one-size-fits-all approach and encouraging a more integrated strategy that addresses the root causes of the condition. This nuanced understanding also aligns with the ongoing evolution of activewear and performance apparel, where brands like LSKD are pushing boundaries to create garments that support bodily function and optimize performance, as detailed in What's Next in Activewear? We Asked the Founder of LSKD. The shift in terminology highlights a comparable trend: recognizing the complexity of human biology and tailoring interventions accordingly.
Beyond the clinical implications, the renaming of PCOS carries a significant emotional weight for those who have navigated the often-confusing and isolating experience of living with the condition. The original diagnosis could feel dismissive, reducing a complex health issue to a singular symptom. The new designation offers a greater sense of validation and understanding, acknowledging the full scope of the challenges individuals face. It also opens the door for more comprehensive research, leading to improved diagnostic tools and more effective treatments. The focus on metabolic health rather than solely reproductive health empowers individuals to take a more proactive role in their well-being, moving beyond reactive symptom management to preventative care and lifestyle adjustments. It’s a shift that echoes the powerful message of self-acceptance and resilience championed by athletes like Ali Krieger, who exemplifies a graceful transition, proving that "retirement" can be a new beginning, as shared in Ali Krieger Says the World Cup Is "Exactly What We Need Right Now".
Ultimately, the renaming of PCOS to PCOS represents a profound step forward in our understanding and treatment of this complex condition. It signifies a move towards a more holistic, patient-centered approach that prioritizes metabolic health and empowers individuals to take control of their well-being. While the change in terminology is a positive development, the real challenge lies in ensuring that healthcare providers and patients alike embrace this broader perspective and translate it into meaningful improvements in diagnosis, treatment, and overall quality of life. The question now becomes: how effectively can we integrate this new understanding into clinical practice and empower individuals to advocate for their own comprehensive care, particularly given the ongoing disparities in healthcare access and awareness?
As someone who was diagnosed with PCOS at the age of 18, it's easy to say I follow sufficient content about the disease to have learned about its recent name change right away. My social media feed was inundated with the news. What for years was a big question mark — and then had a proper name — is now being changed to Polyendocrine Metabolic Ovarian Syndrome, or PMOS.
I'll be honest, my first thought was, well, when do we get a cure? When do we get meds to get rid of this for good? But after my frustration and my immediate need to vent on Instagram Stories, I realized the upside: it opens up the conversation, one which was previously shut down often if cysts didn't appear in an ultrasound.
The name change also now includes the words "metabolic" and "endocrine," encompassing two different areas of the chronic disease which are the most affected. In fact, anyone who's had to deal with PMOS symptoms likely knows that having "cysts" is the least of the problems sometimes. For example, I don't know if I still have cysts; they were never a significant issue for me either. My period was always regular, cramps are painful but not unbearable. But because the cysts appeared on a screen, my diagnosis was confirmed. And years later when they weren't "seen," I was told I didn't necessarily have PCOS — even though I struggle with hirsutism, struggle to lose weight, and sleep apnea, among other symptoms often ignored.
The fact remains that the medical community has struggled to properly manage and handle this disease for years. I have seen so many gynecologists and endocrinologists who, to this day, do not appear to know the right treatment plan for me.
But this name change is indeed a step forward — one towards earlier diagnosis, hopefully more research, and a continuous plan to better understand this complex, frustrating disease. Every body is different, and PMOS does not look the same to everyone, which is why taking the step to remove "cystic" from the name helps better capture the ways this disease can manifest itself.
Life with PMOS can feel like an incessant to-do list: We are told to work out — but not too hard because of cortisol levels. We are told to sleep eight hours a night, yet have insomnia and racing thoughts that keep us awake at night. You can have fruit, but not too much because you might be insulin resistant. You can have carbs but not too many.
The last time I saw a gyno, we explored the possibility of me having Cushing's syndrome, a rare hormonal disorder caused by prolonged exposure to excess cortisol or triggered by pituitary or adrenal tumors. I ultimately ended up testing negative, and though part of me was fearful of a new diagnosis, another part of me welcomed the freedom of not having PMOS.
In speaking to other women with PMOS, I've found others feel similarly about the name change, which feels like a small win in a tiring battle. One woman, Yisel Reyna, said she never had cysts, and so because that symptom was missing, getting the proper diagnosis took much longer. Andrea Cortazar struggled with the birth control she was given to "handle" her cysts, giving her side effects that made her other symptoms worse. For Cortazar, adding the endocrine and metabolic part to the name allows for a better understanding of what could be wrong.
Language can be a tool to raise questions and look for answers. In its renaming, PMOS may no longer be treated monolithically. May this be the change needed to continue evolving the conversation and, hopefully, developing more individualized treatments. We may have a new name, but we'd also like healing.
48794868
Elsa Cavazos is a freelance writer based in Napa, CA. Her work has appeared in Vogue Mexico, Harper's Bazaar, Cosmopolitan, Teen Vogue, Marie Claire, and other publications. Her translation work has appeared in publications such as The Texas Tribune and The Guardian.Read on the original site
Open the publisher's page for the full experience